Longstanding barriers to care combined with an elevated risk of diabetic macular edema (DME) contribute to the disproportionate burden of DME in Native American communities.
Post-COVID conditions (PCC) refer to a diverse array of symptoms that persist for weeks, months, and even years after acute SARS-CoV-2 infection and significantly impact quality of life.
Join us for a live webinar focused on the evolving role of immunotherapy in early-stage resectable non-small cell lung cancer (NSCLC).
Novel targeted therapies offer new hope to slow progression and improve quality of life in meaningful ways for patients with primary biliary cholangitis (PBC).
Platinum-resistant ovarian cancer (PROC) remains one of the most significant challenges in gynecologic oncology; however, novel antibody-drug conjugates (ADCs) and innovative investigational therapies are opening new avenues to improve outcomes.
Join us for a live webinar where expert faculty will provide actionable insights on improving patient identification and engagement for CAR T-cell therapy in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL).
Join us for this live national webinar designed to bridge real-world patient perspectives with the latest advances in metastatic breast cancer (MBC) care.
This dynamic, expert-led live webinar is designed to help you navigate the treatment landscape for advanced gastric and gastroesophageal junction (G/GEJ) adenocarcinomas.
Current evidence-based recommendations for prescribing diabetes medications, including newer pharmacologic classes such as glucagon-like peptide-1 receptor agonists (GLP-1r) and sodium glucose co-transporter-2 inhibitors (SGLTi) medications.
The latest Outpatient Medicine CME updates for nurse practitioners, physician assistants and other healthcare professionals. Taught LIVE by practicing physicians. Relevant, up-to-date studies. Live Stream available. Save $100 w/discount code: ENP100